Articles related to Endocrinology, Diabetes, Metabolism

In this phase 3 double-blind, randomized, 72-week controlled trial of 2,539 adults with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight.

Fast-tracked tirzepatide is looking to join the diabetes-turned-obesity drug market. Additional options in the class could be a boon to patients, given the persisting semiglutide shortage.

The purpose of the randomized controlled study was to see what effect the green-MED diet will have on visceral fat tissue. The randomized controlled study, which lasted 18 months, involved 294 participants in all. Three groups of participants were created: the HDG (healthy dietary recommendations), the MED diet, and the green-MED diet. Participants in both MED groups consumed 440 mg of polyphenols and 28 g of walnuts daily. The green-MED group also ingested three to four cups of green tea daily, 100 g of frozen duckweed plant green smoothie, 800 mg of polyphenols daily, and less meat.

The updated ADA standards have several significant changes. These include: A revised definition of HTN to match that of the ACC and AHA New recommendations for statin use Changes to recommendations around CKD treatment Revised weight loss goals Use of diabetes technology And much more

A mass measuring 4.8 cm by 5.0 cm by 3.9 cm was detected by transabdominal and transvaginal ultrasonography of the abdomen and pelvis. This mass was located along the posterior part of the right hepatic lobe. Following the clinic evaluation, there were two important questions to answer. Initially, was the adrenal tumor malignant or benign? Second, did the lesion secrete hormones?

Are the findings a result of bacterial endocarditis? Resurgent sarcoidosis? An opportunistic fungal pulmonary invasion? Review the workup and cast your vote on what you think the diagnosis is.